valorallure
Posted - 5 days ago
$RPHM Great value even considering cash burn for 1 more year. Biggest risk to me is a reverse merger. I'd prefer a complete liquidation.
Digital_Waffle_Pirate
Posted - 1 week ago
$RPHM studied? prior bios say he completed his doctorate coursework... but he's not a PhD/MD? lol why include without an identifiable credential? must be missing something.
Digital_Waffle_Pirate
Posted - 1 week ago
$RPHM anyone here interested in selling me this pen? or should i go fuck myself and use the google box?
DonCorleone77
Posted - 1 month ago
$RPHM Reneo Pharmaceuticals reports Q4 EPS (70c), consensus (58c) Fourth Quarter and Recent Highlights: The pivotal STRIDE study of mavodelpar in adult patients with primary mitochondrial myopathies did not meet its primary efficacy or secondary efficacy endpoints; The Company implemented cost savings initiatives, including suspension of all mavodelpar development activities and a total workforce reduction of approximately 90%; The Company retained an independent financial advisor to initiate a formal process to evaluate potential strategic alternatives; The Company anticipates it will have approximately $82.0 million in cash, cash equivalents, and short-term investments as of March 31, 2024.
epsguid
Posted - 1 month ago
$RPHM reported a loss of $0.70, consensus was ($0.55) via @eWhispers #epsmiss http://eps.sh/d/rphm
Stock_Titan
Posted - 1 month ago
$RPHM Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
https://www.stocktitan.net/news/RPHM/reneo-pharmaceuticals-reports-fourth-quarter-and-full-year-2023-7xbdqs1s6nq7.html
TI7812
Posted - 01/30/24
$RPHM I wonder what Tang Capital is thinking. They lost at least $15.6M out of $21.1M value in RPHM (assume they still owned 3,330,000 sh on 12/14/23 that they reported owning on 11/14/23 in a 13G filing. What caught my attention is BML buying 1.4m shares after the collapse. RPHM may have about $3.00 cash/sh net and no lead candidate. What will they do? BML likes buying biotechs that have no future in their pipeline with hopes of them closing shop and return cash to shareholders. Wish I knew how he hedges these "bets." no pos
NewbSponge
Posted - 01/30/24
$RPHM What a strange security. Shows up on a screener as having crossed its 20-day SMA while being oversold. Hell of a gap on the chart, induced by what appears to have been a (possible lowball) offer by Tang Capital Partners' Concentra Biosciences, LLC for $1.80. Looks like that offer expired Jan. 5 with no news. Also looks like this Tang/Concentra has a habit of making unsolicited offers, according to some Google-foo. So what now? Was it a lowball offer that sank the stock price? If so, was it intentional? Did someone build a short position before making the offer? Is RPHM now unfairly low in price? Had a positive MACD cross right at the Jan. 5 deadline, but price has largely been flat. Anyone with insight as to what's next?
EarningsInsider
Posted - 3 months ago
Reneo Pharmaceuticals Sees Short Interest Decrease from 1,750,000 shares to 1,480,000 shares. $RPHM https://www.marketbeat.com/stocks/NASDA
tickeron
Posted - 3 months ago
Do you agree with the A.I. prediction? $RPHM RSI Indicator left the oversold zone. View odds of downtrend. https://srnk.us/go/4977840
BigLineSwings
Posted - 3 months ago
$RPHM hmm picked me up @1.42 starter .
_Baba_9
Posted - 3 months ago
$RPHM
_Baba_9
Posted - 3 months ago
buying more $RPHM today
FeliciaMath
Posted - 3 months ago
sold $rphm today too
_Baba_9
Posted - 3 months ago
$RPHM
speedrr
Posted - 3 months ago
$RPHM
TampaD
Posted - 3 months ago
$RPHM 🙃
DanielBogdanov
Posted - 3 months ago
$RPHM Waht is going on here? The way is up or down? 🙄
speedrr
Posted - 3 months ago
$RPHM
_Baba_9
Posted - 3 months ago
$RPHM still here
speedrr
Posted - 3 months ago
$RPHM
speedrr
Posted - 3 months ago
$RPHM when do we think we get a reply re: tangs offer?
FeliciaMath
Posted - 3 months ago
bought some $rphm at 1.66 a little high but ok
Surfude
Posted - 3 months ago
$RPHM -13D filed with the SEC on 12/26. buyout proposal is for $1.80 with and expires on Jan 5--Go look for your self this is public information,
_Baba_9
Posted - 3 months ago
$RPHM
G101SPM
Posted - 3 months ago
@Surfude @RamenLives on $RPHM --- we have the 13D but nothing on formal bid. Send us what you have or the reference source. Thanks.
RamenLives
Posted - 4 months ago
$RPHM decided to pull profits now...with no official offer you never know if someone is playing games. Good luck longs!
Surfude
Posted - 4 months ago
$RPHM --No brainer--buyout offered announced 12/26 and again 12/27 for $1.80.
G101SPM
Posted - 4 months ago
@RamenLives per request $RPHM $1.62 carries SPM 55.14 (high risk) tag as a "shell play" after failure of the mid-stage pivotal STRIDE study of its investigational candidate, mavodelpar (REN001) and absence of any other investigational candidates in its pipeline paves the way for a "reinvention." ^^^ Reneo announced that its lead drug candidate and sole clinica failed to meet either primary or secondary endpoints in the pivotal STRIDE study in primary mitochondrial myopathie. Reneo expects to reduce its workforce by approximately 70%. We note that the company currently has a cash position of over $100M, which we expect to last at least into 2025. CONSENSUS: Downgrading from Buy to Neutral, lowering 12-month target to $1.50 from the prior $30 per share. 12.15.23 Reneo Pharmaceuticals (RPHM) downgraded to Hold from Buy at Jefferies 12.15.23xReneo Pharmaceuticals (RPHM) downgraded to Market Perform from Outperform at Leerink Partners
